Which stocks in any sector do Indian mutual fund managers prefer most? — August 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 466 funds | 2.59% | ₹64,170 Cr |
| 2 | Divi's Laboratories Limited | 337 funds | 2.57% | ₹34,186 Cr |
| 3 | Torrent Pharmaceuticals Limited | 335 funds | 2.04% | ₹15,503 Cr |
| 4 | Cipla Limited | 291 funds | 1.51% | ₹23,225 Cr |
| 5 | Dr. Reddy's Laboratories Limited | 259 funds | 1.42% | ₹16,882 Cr |
| 6 | Lupin Limited | 227 funds | 1.53% | ₹14,194 Cr |
| 7 | Mankind Pharma Limited | 214 funds | 1.08% | ₹11,337 Cr |
| 8 | Aurobindo Pharma Limited | 207 funds | 1.62% | ₹10,466 Cr |
| 9 | Glenmark Pharmaceuticals Limited | 202 funds | 1.35% | ₹8,934 Cr |
| 10 | Laurus Labs Limited | 198 funds | 2.74% | ₹8,452 Cr |
| 11 | Ajanta Pharma Limited | 194 funds | 0.97% | ₹8,008 Cr |
| 12 | Biocon Limited | 186 funds | 1.01% | ₹13,742 Cr |
| 13 | Alkem Laboratories Limited | 183 funds | 1.14% | ₹12,312 Cr |
| 14 | Zydus Lifesciences Limited | 169 funds | 1.08% | ₹5,811 Cr |
| 15 | Sai Life Sciences Limited | 169 funds | 1.84% | ₹9,317 Cr |
| 16 | Abbott India Limited | 166 funds | 0.85% | ₹4,314 Cr |
| 17 | Anthem Biosciences Limited | 158 funds | 0.68% | ₹5,012 Cr |
| 18 | Acutaas Chemicals Ltd | 158 funds | 1.77% | ₹3,701 Cr |
| 19 | IPCA Laboratories Limited | 157 funds | 1.17% | ₹15,747 Cr |
| 20 | Gland Pharma Limited | 150 funds | 1.91% | ₹12,407 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of August 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.